Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant - PubMed (original) (raw)
Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant
Kahori Kurosaka et al. J Immunol. 2005.
Abstract
Mammalian antimicrobial proteins, such as defensins and cathelicidin, have stimulating effects on host leukocytes. Cathelin-related antimicrobial peptide (CRAMP), the orthologue of human cathelicidin/LL-37, is the sole identified murine cathelicidin. CRAMP has been shown to have both antimicrobial and angiogenic activities. However, whether CRAMP, like human cathelicidin/LL-37, also exhibits a direct effect on the migration and function of leukocytes is not known. We have observed that CRAMP, like LL-37, was chemotactic for human monocytes, neutrophils, macrophages, and mouse peripheral blood leukocytes. CRAMP also induced calcium mobilization and the activation of MAPK in monocytes. CRAMP-induced calcium flux in monocytes was desensitized by MMK-1, an agonistic ligand specific for formyl peptide receptor-like-1 (FPRL1), and vice versa, suggesting the use of FPRL1 by CRAMP as a receptor. Furthermore, CRAMP induced the chemotaxis of human embryonic kidney 293 cells transfected with either FPRL1 or mouse formyl peptide receptor-2, the mouse homologue of FPRL1, but not by untransfected parental human embryonic kidney 293 cells, confirming the use of FPRL1/mouse formyl peptide receptor-2 by CRAMP. Injection of CRAMP into mouse air pouches resulted in the recruitment predominantly of neutrophils and monocytes, indicating that CRAMP acts as a chemotactic factor in vivo. Finally, simultaneous administration of OVA with CRAMP to mice promoted both humoral and cellular Ag-specific immune responses. Thus, CRAMP functions as both a chemoattractant for phagocytic leukocytes and an enhancer of adaptive immune response.
Similar articles
- LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.
De Yang, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O. De Yang, et al. J Exp Med. 2000 Oct 2;192(7):1069-74. doi: 10.1084/jem.192.7.1069. J Exp Med. 2000. PMID: 11015447 Free PMC article. - Temporin A and related frog antimicrobial peptides use formyl peptide receptor-like 1 as a receptor to chemoattract phagocytes.
Chen Q, Wade D, Kurosaka K, Wang ZY, Oppenheim JJ, Yang D. Chen Q, et al. J Immunol. 2004 Aug 15;173(4):2652-9. doi: 10.4049/jimmunol.173.4.2652. J Immunol. 2004. PMID: 15294982 - An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7.
Nagaoka I, Tamura H, Hirata M. Nagaoka I, et al. J Immunol. 2006 Mar 1;176(5):3044-52. doi: 10.4049/jimmunol.176.5.3044. J Immunol. 2006. PMID: 16493063 - A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4.
Le Y, Shen W, Li B, Gong W, Dunlop NM, Wang JM. Le Y, et al. Forum (Genova). 1999 Oct-Dec;9(4):299-314. Forum (Genova). 1999. PMID: 10611407 Review.
Cited by
- The inflammatory response to cell death.
Rock KL, Kono H. Rock KL, et al. Annu Rev Pathol. 2008;3:99-126. doi: 10.1146/annurev.pathmechdis.3.121806.151456. Annu Rev Pathol. 2008. PMID: 18039143 Free PMC article. Review. - A non-bactericidal cathelicidin provides prophylactic efficacy against bacterial infection by driving phagocyte influx.
Yang Y, Wu J, Li Q, Wang J, Mu L, Hui L, Li M, Xu W, Yang H, Wei L. Yang Y, et al. Elife. 2022 Feb 23;11:e72849. doi: 10.7554/eLife.72849. Elife. 2022. PMID: 35195067 Free PMC article. - Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to microbial compounds.
Amatngalim GD, Nijnik A, Hiemstra PS, Hancock RE. Amatngalim GD, et al. Inflammation. 2011 Oct;34(5):412-25. doi: 10.1007/s10753-010-9248-6. Inflammation. 2011. PMID: 20811938 - Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35.
Qin CX, Norling LV, Vecchio EA, Brennan EP, May LT, Wootten D, Godson C, Perretti M, Ritchie RH. Qin CX, et al. Br J Pharmacol. 2022 Oct;179(19):4617-4639. doi: 10.1111/bph.15919. Epub 2022 Jul 29. Br J Pharmacol. 2022. PMID: 35797341 Free PMC article. Review. - Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense.
Leiva-Juárez MM, Kolls JK, Evans SE. Leiva-Juárez MM, et al. Mucosal Immunol. 2018 Jan;11(1):21-34. doi: 10.1038/mi.2017.71. Epub 2017 Aug 16. Mucosal Immunol. 2018. PMID: 28812547 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases